|
|
|
Tuesday, July 15,
2003
|
08:30-11:00 |
|
COLUMBIA
B |
|
|
PL13 Plenary
Session: CORONARY
ARTERY DISEASE: PREVENTION, DRUG THERAPY,
MODIFICATION OF LIPOPROTEINS
Chairpersons:
C. Rosendorff,
Bronx, NY, USA
U. Thadani, Oklahoma City, OK, USA |
|
|
08:30 |
GUIDELINES FOR THE PREVENTION OF CORONARY
HEART DISEASE: WHAT DOES REALITY LOOK LIKE?
FINDINGS FROM GERMANY AND OTHER EUROPEAN COUNTRIES (Invited Lecture)
U. Keil,
University of Muenster, Muenster, Germany |
|
|
08:45 |
BETA BLOCKERS IN ISCHEMIC HEART DISEASE AS
“CARDIOPROTECTION” IN THE ERA OF ACE INHIBITION AND RAPID
REVASCULARIZATION (Invited Lecture)
B.F. Uretsky,
University of Texas Medical Branch at Galveston, Galveston, TX, USA |
|
|
09:00 |
MANAGEMENT OF STABLE ANGINA: DRUGS, DEVICES, STENTS OR
CORONARY BYPASS SURGERY (Invited Lecture)
U. Thadani,
University of Oklahoma Health Sciences Center and
VA Medical Center, Oklahoma City, Oklahoma, USA |
|
|
09:15 |
REDUCING CARDIOVASCULAR EVENTS-FOCUS ON NEW TRIALS (Invited Lecture)
R. DiBianco,
Washington Adventist Hospital, Takoma Park, MD, USA |
|
|
09:30 |
STATINS AND STROKE: THE MODE OF ACTION IN STROKE PREVENTION AND
THERAPY (Invited Lecture)
R. Paoletti,
C. Bolega, University of Milan, Milan, Italy |
|
|
09:45 |
ROSUVASTATIN: A NEW AND POTENT CHOLESTEROL
REDUCING AGENT (Invited Lecture)
W.V. Brown,
Emory University/Atlanta VAMC, Atlanta, GA, USA |
|
|
10:00 |
ATHEROSCLEROSIS REGRESSION BY LIPID LOWERING (Invited Lecture)
C. Rosendorff,
Mount Sinai School of Medicine, New York, V.A. Medical Center, Bronx, NY, USA |
|
|
10:15 |
THE
ROLE OF THE MACROPHAGE IN REVERSE CHOLESTEROL TRANSPORT
IN VIVO (Invited Lecture)
O. Stein,
Y. Stein, Hadassah Hebrew University Medical School, Jerusalem, Israel |
|
|
10:30 |
PLEIOTROPIC ACTIONS OF STATIN AGENTS INCLUDING APPLICABILITY TO CHF
(Invited Lecture)
R.S. Wright, Mayo Clinic, Rochester,
MN, USA |
|
|
10:45 |
NEW UNDERSTANDING OF ATHEROSCLEROSIS: IS
THE LIPID THEORY DEBUNKED? (Invited Lecture)
W.B. Strawn, C.M. Ferrario, Wake
Forest University School of Medicine, Winston-Salem,
NC, USA |
|
|
11:00 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
|
TUESDAY, JULY 15,
2003 |
|
08:30-11:15 |
|
COLUMBIA
C |
|
|
S55
Session: SURGICAL
ASPECTS / VALVULAR HEART DISEASE /
CONGENITAL HEART DISEASE
Chairpersons: A.
Kumar, Amritsar, India
L.S.C. Czer,
Los Angeles, CA, USA |
|
|
08:30 |
ROLE OF MIXED VENOUS OXYGEN SATURATION
MEASUREMENT IN ADVANCED HEART FAILURE
G. Bhat,
University of Louisville, Jewish Hospital, Louisville, KY, USA |
|
|
08:45 |
THREE-DIMENSIONAL OPTICAL COHERENCE
TOMOGRAPHY: APPLICATIONS TO CHICK EMBRYO CARDIAC DEVELOPMENT AND
DROSOPHILA MELANOGASTER CIRCULATORY FUNCTION
M.A. Choma,
T.M. Yelbuz, L. Thrane, M.L. Kirby, J.A. Izatt, Duke University, Durham,
NC, USA, Germay, Denmark |
|
|
09:00 |
EXPERIENCE WITH A NEW BIOLOGICAL VALVE: EARLY
AND MID-TERM RESULTS
L.A. Bockeria, B.N. Sabirov,
S.B. Zaets, I.I. Kagramanov, I.V. Kokshenev,
V.T. Kostava, D.B. Drobot, New Jersey Medical
School, Newark, NJ, USA, Russia |
|
|
09:15 |
AFTERLOAD MINIMIZATION IN AORTIC STENOSIS BY
LEFT VENTRICULAR DYNAMICS/VALVE ORIFICE MATCHING DURING EJECTION
S. Schouvey,
K. Isaaz,
University of St. Etienne, St. Etienne, France |
|
|
09:30 |
CYTOKINE RESPONSE POST-CARDIOPULMONARY BYPASS IN CHILDREN UNDERGOING
CONGENITAL HEART SURGERY
A. Madhok,
V. Haridas, M. Gandhi, V.A. Parnell, K. Ojamaa, D. Chowdhury, Schneider
Children’s Hospital, New Hyde Park, NY, USA |
|
|
09:45 |
ECHOCARDIOGRAPHIC CORRELATES OF MITRAL VALVE
PROLAPSE AMONG ADULT FILIPINO PATIENTS: PHILIPPINE HEART CENTER
EXPERIENCE
F.S. Agno,
J. Navarro, A. Junia, E. Collong, R. Jara, Weill Medical College of
Cornell University, New York, NY, USA, Phillippines |
|
|
10:00 |
TRIPLE VALVE SURGERY – EXPERIENCE IN 545 PATIENTS
N.D. Radovanovic, J.J. Lavac, S.R. Nicin, B.B. Mihajlovic, J.J.
Selestiansky, P. Kovacevic, M.M.
Fabri, Z.S. Jonjev, University Clinic of Cardiovascular Surgery, Sremska
Kamenica, Vojvodina, Serbia & Montenegro |
|
|
10:15 |
FAVOURABLE OUTCOME OF PREGNANCY IN 29 CASES OF
EISENMENGER’S SYNDROME
A. Kumar,
V. Mohan, D. Kaur, GOVT Medical College, Amritsar, Punjab, India
|
|
|
10:30 |
RISK INDEX AND PREDICTOR OF INTENSIVE CARE
UNIT (ICU) MORTALITY AMONG PEDIATRIC PATIENTS AGE 19 & BELOW WITH
CHRONIC RHEUMATIC VALVULAR REGURGITATION - A 5-YEAR NONCONCURRENT COHORT
STUDY
S.P. Paragas,
Philippine Heart Center, Quezon City, Philipines |
|
|
10:45 |
IN-VITRO QUANTIFICATION OF FACTORS THAT
OVERWHELM LEAFLET COMPENSATORY MECHANISMS FOR MITRAL REGURGITATION IN
HEART FAILURE
V. Vijay,
B. Kolanuvada, V. Jorapur, A. Nellutla, S. Dommaraju, K. McCusker, M.
Sarabu, E. Zias, T. Mitchell, New York
Medical College, Valhalla, NY, USA |
|
|
11:00 |
INTERVENTION FOR REVASCULARIZATION IN DIABETIC
PATIENTS: A COMPARISON OF STENT IMPLANTATION, BALLOON ANGIOPLASTY AND
BYPASS SURGERY
T. Sahlev, H. Gilutz, J. Zellinger, G. Sosna, D. Pilpel, I. Reuven,
A. Porath, Soroka Medical Center, Beer Sheva,
Israel |
|
|
11:15 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
|
TUESDAY, JULY 15,
2003 |
|
11:15 - 14:00
|
|
COLUMBIA
B |
|
|
PL14 Plenary
Session: NEW
HORIZONS IN THE MANAGEMENT OF HEART FAILURE
Chairpersons: U.
Elkayam,
Los Angeles, CA, USA
M.R.
Johnson,
Madison, WI, USA |
|
|
11:15 |
HOSPITALIZATION FOR HEART FAILURE:
PATHOPHYSIOLOGY AND MANAGEMENT (Invited Lecture)
L. Klein, M. Gheorghiade, Northwestern University, Feinberg
Medical School, Chicago, IL, USA |
|
|
11:30 |
DECOMPENSATED HEART FAILURE - NEW VERSUS OLD
THERAPY (Invited Lecture)
U. Elkayam,
University of Southern California, CA, USA |
|
|
11:45 |
EXERCISE TRAINING IN PATIENTS WITH
CHRONIC HEART FAILURE: WHY, WHEN AND HOW MUCH? (Invited Lecture)
G. Gorge,
T. Meyer, Klinikum Saarbrucken, Saarbrucken, Germany |
|
|
12:00 |
NEW THERAPEUTIC APPROACHES FOR
CONGESTIVE HEART FAILURE (Invited
Lecture)
R.C. Bourge,
University of Alabama at Birmingham, Birmingham, AL, USA |
|
|
12:15 |
TARGETING PHOSPHOLAMBAN AS A
THERAPEUTIC MODALITY IN HEART FAILURE (Invited Lecture)
E.G. Kranias,
University of Cincinnati, Cincinnati, OH, USA |
|
|
12:30 |
NEW THERAPIES FOR HEART FAILURE (Invited
Lecture)
R.E. Hobbs,
Cleveland Clinic Foundation, Cleveland, OH, USA |
|
|
12:45 |
THE MANAGEMENT OF
HEART FAILURE IN 2003 - PEARLS AND PITFALLS (Invited Lecture)
M.R. Johnson,
University of Wisconsin Medical School, Madison, WI, USA |
|
|
13:00 |
THE EVOLVING ROLE OF ULTRAFILTRATION
THERAPY FOR THE DECOMPENSATED HEART
FAILURE PATIENT: NOT JUST FOR THE NEPHROLOGIST
ANYMORE (Invited Lecture)
M. Saltzberg,
J. Pouliot, Midwest Heart Specialists, Downers Grove, IL, USA |
|
|
13:15 |
IS
PALLIATIVE CARE USEFUL FOR PATIENTS WITH SEVERE HEART FAILURE
H.J. Geschwind,
University of Paris XII, Sceaux, Cretiel, France |
|
|
13:30 |
VASCULAR SMOOTH MUSCLE CELL APOPTOSIS IN AORTIC DISEASES: ROLE OF
ANGIOTENSIN II SIGNALING VIA ANGIOTENSIN II TYPE 2 RECEPTOR
H. Nagashima,
Y. Sakomura, Y. Aoka, S. Aomi, H. Kasanuki, Tokyo Women's Medical University, Tokyo, Japan
|
|
|
13:45 |
DOES CHRONIC ACE-INHIBITOR ADMINISTRATION
AFFECT INCIDENCE OF CONTRAST NEPHROPATHY IN PATIENTS WITH PRE-EXISTING
RENAL INSUFFICIENCY UNDERGOING CORONARY ANGIOGRAM? A RETROSPECTIVE
ANALYSIS
D. Kamra,
E. Huang, K. Ranganna, J. Lee, H. Fisher, B. Cuhaci, Z. Ahmed, Hahnemann
University Hospital, Philadelphia, PA, USA |
|
|
|
|
|
|
TUESDAY, JULY 15,
2003 |
|
11:15 - 13:45 |
|
COLUMBIA
C |
|
|
S56
Session: MODIFICATION OF RISK FACTORS AND CAD , DYSLIPOPROTEINEMIA,
DIABETES MELLITUS, SECONDARY PREVENTION
Chairpersons:
Y. Charuzi,
Los Angeles, CA, USA
M. Motro, Tel Aviv, Israel |
|
|
11:15 |
CORONARY ARTERY BYPASS GRAFTING (CABG)-
OUTCOMES IN PATIENTS WITH HISTORY OF
ILLICIT DRUG USE
P. Misra,
P.C. Reddy, G.C. Caldito, M.C. Mancini, Louisiana State University
Health Sciences Center, Shreveport, LA, USA |
|
|
11:30 |
EFFECTIVENESS OF MULTIDISCIPLINARY PATIENT COUNSELING IN
REDUCING CARDIOVASCULAR DISEASE RISK FACTORS THROUGH NON-PHARMACOLOGICAL
INTERVENTION: RESULTS FROM THE HEALTHY HEART PROGRAM
D. R Simpson, B.G
Dixon, P Bolli, Hotel Dieu Health Sciences Hospital, St.
Catharines, Ontario, Canada |
|
|
11:45 |
IMPACT OF INTENSIVE CORONARY ARTERY DISEASE
MANAGEMENT ON MEDICATION ADHERENCE AND CLINICAL OUTCOMES
L. Houston-Feenstra,
R.V. Jutzy, K. Jutzy, L. Lianov, S. Lee, S. Dyer, Loma Linda University Medical Center, Loma
Linda, CA, USA
|
|
|
12:00 |
STATINS NORMALIZE ACUTE REDUCTION IN
ANTIBODIES TO MDA MODIFIED LDL AFTER A POLYUNSATURATED FATTY MEAL
M.T. Harris, G. Saliashvili, W.W. Davis, N.A. Le, M.
Moussa,
W.V. Brown, Emory University School of Medicine, Atlanta, GA, USA |
|
|
12:15 |
LEVEL OF ADHERANCE TO NCEP ATP III GUIDELINES
- ARE WE DOING IT
S.R. Punnam,
Crozer Chester Medical Center, Temple University, Philadelphia, PA, USA |
|
|
12:30 |
SECONDARY RISK FACTORS IN CARDIAC SURGERY
P.C. Shah, W.J. Davis III, M. Vaynblat, M. Chaviarelli, R.
Fazylov, J.N.Cunningham Jr, Maimonides Medical Center, SUNY Health Science Center, Brooklyn NY, USA
|
|
|
12:45 |
SIMVASTATIN TREATMENT IMPROVES ARTERIAL
COMPLIANCE IN THE THIGH IN TWO MONTHS IN HIGH RISK PATIENTS
G. Saliashvili, M.T.
Harris, W.W. Davis, N.A. Le,
W.V. Brown, Emory University of Medicine, Atlanta,
Atlanta VA Medical Center, Decatur, GA, USA
|
|
|
13:00 |
INSULIN IMPROVES ISCHEMIA-REPERFUSED
CARDIOMYOCYTE CONTRACTILE FUNCTIONAL RECOVERY: KEY ROLE OF AKT
F. Gao,
B. Zhang, H.F. Zhang, B.L. Lopez, T.A. Christopher, X.L. Ma, Fourth Military Medical University, Xian,
China, USA |
|
|
13:15 |
ANTI-ISCHEMIC EFFECT OF TRIMETAZIDINE IN
DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE
G.M.C. Rosano,
C. Vitale, B. Sposato, M. Fini, S. Chierchia, San Raffaele Roma, Rome, Italy
|
|
|
13:30 |
COMPUTERIZED COMMUNITY CHOLESTEROL CONTROL
(4C): AN EFFECTIVE MASSIVE SECONDARY PREVENTION INTERVENTION
H. Gilutz,
J. Zelingher, Y. Henkin, D.Y. Bonneh, Z. Liss, R. Peleg, M. Mayslus,
R. Ilia, D. Vardy, A. Porath, Soroka Medical Center, Beer Sheva, Israel |
|
|
|
Cardiology
Online